ConductScience.org, home

Paper39927770

Recent developments in Aspergillus fumigatus research: diversity, drugs, and disease.

Kordana N and 4 others. Microbiol Mol Biol Rev, 2025. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Recent developments in Aspergillus fumigatus research: diversity, drugs, and disease. Papers, record 39927770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39927770

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent developments in Aspergillus fumigatus research: diversity, drugs, and disease.
PubMed
Journal
Microbiol Mol Biol Rev
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
6.5, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aspergillus fumigatusMajor topic
AspergillosisMajor topic
Antifungal AgentsMajor topic
Humans
Drug Resistance, Fungal
Animals
Triazoles

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI130128NIAID NIH HHSUnited StatesR01AI130128PubMed and NIHNIH RePORTER
T32AI007519HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)T32AI007519PubMed and NIHNIH RePORTER
T32 AI007519NIAID NIH HHSUnited StatesT32AI007519PubMed and NIHNIH RePORTER
R01 AI139133NIAID NIH HHSUnited StatesR01AI139133PubMed and NIHNIH RePORTER
T32HL134598HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)T32HL134598PubMed and NIHNIH RePORTER
R01AI139133HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)R01AI139133PubMed and NIHNIH RePORTER
T32 HL134598NHLBI NIH HHSUnited StatesT32HL134598PubMed and NIHNIH RePORTER
005808G223-CramerCystic Fibrosis Foundation (CFF)PubMedPubMed
R01 AI146121NIAID NIH HHSUnited StatesR01AI146121PubMed and NIHNIH RePORTER
R01 AI181215NIAID NIH HHSUnited StatesR01AI181215PubMed and NIHNIH RePORTER
R01AI181215, R01AI130128HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)R01AI181215PubMed and NIHNIH RePORTER

Download CSV of grants

References384

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126667837Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium.Infect Immun2015https://conductscience.org/library/papers/26667837PubMed
235680499Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis.Vaccine2022https://conductscience.org/library/papers/35680499PubMed
333593969A Heterogeneously Expressed Gene Family Modulates the Biofilm Architecture and Hypoxic Growth of Aspergillus fumigatus.mBio2021https://conductscience.org/library/papers/33593969PubMed
438130371Isolated renal and urinary tract aspergillosis: a systematic review.Ther Adv Urol2023https://conductscience.org/library/papers/38130371PubMed
532291301Human Neutrophils Produce Antifungal Extracellular Vesicles against Aspergillus fumigatus.mBio2020https://conductscience.org/library/papers/32291301PubMed
635560045
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
Am J Hematol2023https://conductscience.org/library/papers/35560045PubMed
735652640Horizontal Gene Transfer of Triazole Resistance in Aspergillus fumigatus.Microbiol Spectr2022https://conductscience.org/library/papers/35652640PubMed
838990800Unraveling the genomic diversity and virulence of human fungal pathogens through pangenomics.PLoS Pathog2024https://conductscience.org/library/papers/38990800PubMed
928423062Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression.PLoS Pathog2017https://conductscience.org/library/papers/28423062PubMed
1032357408Evaluation of Droplet Digital Polymerase Chain Reaction (ddPCR) for the Absolute Quantification of Aspergillus species in the Human Airway.Int J Mol Sci2020https://conductscience.org/library/papers/32357408PubMed
1127048799Deacetylation of Fungal Exopolysaccharide Mediates Adhesion and Biofilm Formation.mBio2016https://conductscience.org/library/papers/27048799PubMed
1233593906Dual-purpose isocyanides produced by Aspergillus fumigatus contribute to cellular copper sufficiency and exhibit antimicrobial activity.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33593906PubMed
1334173659
Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
J Pediatric Infect Dis Soc2021https://conductscience.org/library/papers/34173659PubMed
1439189854Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis.Am J Respir Crit Care Med2024https://conductscience.org/library/papers/39189854PubMed
1534790195Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific.Front Immunol2021https://conductscience.org/library/papers/34790195PubMed
1638403258Time-resolved fluoroimmunoassay for Aspergillus detection based on anti-galactomannan monoclonal antibody from stable cell line.Anal Biochem2024https://conductscience.org/library/papers/38403258PubMed
1722108383Identification and characterization of an Aspergillus fumigatus "supermater" pair.mBio2011https://conductscience.org/library/papers/22108383PubMed
1825537876Common severe infections in chronic granulomatous disease.Clin Infect Dis2015https://conductscience.org/library/papers/25537876PubMed
1928947643Interleukin 1α Is Critical for Resistance against Highly Virulent Aspergillus fumigatus Isolates.Infect Immun2017https://conductscience.org/library/papers/28947643PubMed
2032956405NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis.PLoS Pathog2020https://conductscience.org/library/papers/32956405PubMed

See all 384 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42655757The Janus Face of Aspergillus in Fish Aquaculture: From Pathogenic Threat to Functional Feed Additive.Vet Sci2026https://conductscience.org/library/papers/42655757PubMed
42655049Antifungal Susceptibility and Cyp51A Gene Variation Analysis of Aspergillus fumigatus Isolated from Soils in Tea-Growing Areas of Guizhou, China.Microorganisms2026https://conductscience.org/library/papers/42655049PubMed
42615624Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus.mBio2026https://conductscience.org/library/papers/42615624PubMed
42447002The power of ten: report from the 10th American Society for Microbiology Conference on Biofilms.J Bacteriol2026https://conductscience.org/library/papers/42447002PubMed
42132439A ceramide synthase is important for filamentous fungal biofilm morphology and antifungal drug susceptibility.mBio2026https://conductscience.org/library/papers/42132439PubMed
42084394Multi-omics profiling of fungal balls in chronic pulmonary aspergillosis patients reveals microbiome dynamics and metabolic adaptations.mBio2026https://conductscience.org/library/papers/42084394PubMed
42060100Investigation of chitinase B1 inhibitors targeting the cell wall biosynthetic machinery in Aspergillus fumigatus through integrated molecular dynamics and QM/MM.Folia Microbiol (Praha)2026https://conductscience.org/library/papers/42060100PubMed
41968318RTA-like proteins regulate azole susceptibility by affecting the expression of the oxidoreductase gene oxrA in Aspergillus fumigatus.BMC Microbiol2026https://conductscience.org/library/papers/41968318PubMed
41968250Electrophoretic Mobility Shift Assay in Aspergillus fumigatus.Methods Mol Biol2026https://conductscience.org/library/papers/41968250PubMed
41948395Nebulized Liposomal Amphotericin B as an Alternative Therapy for an Aspergillus Tracheal Plaque.Case Rep Infect Dis2026https://conductscience.org/library/papers/41948395PubMed
41928566HosA-mediated epigenetic regulation of growth, virulence, and secondary metabolism in Aspergillus fumigatus.Virulence2026https://conductscience.org/library/papers/41928566PubMed
41871161Functional and molecular characterization of Aspergillus fumigatus phosphoglucomutase (Pgm): a potential target for antifungal therapy.J Med Microbiol2026https://conductscience.org/library/papers/41871161PubMed
41860106High-Volume Culture Improves Diagnostic Yield of Aspergillus Species From Sputum.Mycoses2026https://conductscience.org/library/papers/41860106PubMed
41597755Novel Genetic Diversity and Geographic Structures of Aspergillus fumigatus (Order Eurotiales, Family Aspergillaceae) in the Karst Regions of Guizhou, China.Microorganisms2026https://conductscience.org/library/papers/41597755PubMed
41436940Geographically structured genotypes and resistance clustering in Aspergillus fumigatus.Eur J Clin Microbiol Infect Dis2026https://conductscience.org/library/papers/41436940PubMed
41343262Emergence, function, and therapeutic strategies to target the PD-1/PD-L1 immune checkpoint during pathogenic fungal infections.Virulence2025https://conductscience.org/library/papers/41343262PubMed
40232283Human immunity to fungal infections.J Exp Med2025https://conductscience.org/library/papers/40232283PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39927770

GET https://conductscience.org/api/papers/v1/39927770/references?page=2